QUEST DIAGNOSTICS INC - DGX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02, 2026 | — | A | A | 198.0 | 0.0 | 0.0 | 198.0 | View | |
| Mar 11, 2026 | — | A | A | 215.0 | 0.0 | 0.0 | 215.0 | View | |
| Mar 06, 2026 | SVP, Clinical Solutions | S | D | 2,628.0 | 204.86 | 538,372.08 | 13,441.0 | View | |
| Mar 06, 2026 | SVP, Clinical Solutions | A | A | 6,200.0 | 204.86 | 1,270,132.0 | 16,069.0 | View | |
| Mar 06, 2026 | SVP, Corp. Controller & CAO | F | D | 750.0 | 204.86 | 153,645.0 | 35,196.0 | View | |
| Mar 06, 2026 | SVP, Corp. Controller & CAO | A | A | 1,473.0 | 204.86 | 301,758.78 | 35,946.0 | View | |
| Mar 06, 2026 | SVP for Diagnostic Services | S | D | 2,855.0 | 206.21 | 588,729.55 | 15,198.0 | View | |
| Mar 06, 2026 | SVP for Diagnostic Services | F | D | 2,827.0 | 204.86 | 579,139.22 | 18,053.0 | View | |
| Mar 06, 2026 | SVP for Diagnostic Services | A | A | 5,682.0 | 204.86 | 1,164,014.52 | 20,880.0 | View | |
| Mar 06, 2026 | CEO and President | F | D | 26,414.0 | 204.86 | 5,411,172.04 | 142,423.0 | View | |
| Mar 06, 2026 | CEO and President | A | A | 51,652.0 | 204.86 | 10,581,428.72 | 168,837.0 | View | |
| Mar 06, 2026 | SVP & General Counsel | S | D | 3,878.0 | 206.21 | 799,682.38 | 37,557.0 | View | |
| Mar 06, 2026 | SVP & General Counsel | F | D | 3,354.0 | 204.86 | 687,100.44 | 41,435.0 | View | |
| Mar 06, 2026 | SVP & General Counsel | A | A | 7,232.0 | 204.86 | 1,481,547.52 | 44,789.0 | View | |
| Mar 06, 2026 | SVP & Chief Commercial Officer | F | D | 2,326.0 | 204.86 | 476,504.36 | 11,864.0 | View | |
| Mar 06, 2026 | SVP & Chief Commercial Officer | A | A | 5,682.0 | 204.86 | 1,164,014.52 | 14,190.0 | View | |
| Mar 06, 2026 | EVP, Regional Businesses | S | D | 5,558.0 | 206.21 | 1,146,115.18 | 67,122.0 | View | |
| Mar 06, 2026 | EVP, Regional Businesses | F | D | 5,806.0 | 204.86 | 1,189,417.16 | 72,680.0 | View | |
| Mar 06, 2026 | EVP, Regional Businesses | A | A | 11,364.0 | 204.86 | 2,328,029.04 | 78,486.0 | View | |
| Mar 06, 2026 | Executive Vice President & CFO | F | D | 7,720.0 | 204.86 | 1,581,519.2 | 33,268.0 | View | |
| Mar 06, 2026 | Executive Vice President & CFO | A | A | 13,947.0 | 204.86 | 2,857,182.42 | 40,988.0 | View | |
| Mar 04, 2026 | SVP & Chief Commercial Officer | F | D | 188.0 | 204.86 | 38,513.68 | 8,508.0 | View | |
| Mar 04, 2026 | SVP, Clinical Solutions | F | D | 205.0 | 204.86 | 41,996.3 | 9,869.0 | View | |
| Mar 04, 2026 | SVP for Diagnostic Services | S | D | 410.0 | 207.73 | 85,169.3 | 15,198.0 | View | |
| Mar 04, 2026 | SVP for Diagnostic Services | F | D | 230.0 | 204.86 | 47,117.8 | 15,608.0 | View | |
| Mar 04, 2026 | CEO and President | S | D | 10,000.0 | 212.52 | 2,125,200.0 | 117,185.0 | View | |
| Mar 04, 2026 | CEO and President | F | D | 2,968.0 | 204.86 | 608,024.48 | 127,185.0 | View | |
| Mar 04, 2026 | SVP & General Counsel | S | D | 526.0 | 207.73 | 109,265.98 | 37,557.0 | View | |
| Mar 04, 2026 | SVP & General Counsel | F | D | 288.0 | 204.86 | 58,999.68 | 38,083.0 | View | |
| Mar 04, 2026 | Executive Vice President & CFO | F | D | 869.0 | 204.86 | 178,023.34 | 27,041.0 | View | |
| Mar 04, 2026 | EVP, Regional Businesses | S | D | 632.0 | 207.73 | 131,285.36 | 67,122.0 | View | |
| Mar 04, 2026 | EVP, Regional Businesses | F | D | 648.0 | 204.86 | 132,749.28 | 67,754.0 | View | |
| Mar 04, 2026 | SVP, Corp. Controller & CAO | F | D | 88.0 | 204.86 | 18,027.68 | 34,473.0 | View | |
| Feb 20, 2026 | — | L | A | 7.0 | 183.51 | 1,284.57 | 9,057.0 | View | |
| Feb 20, 2026 | CEO and President | A | A | 73,225.0 | 0.0 | 0.0 | 73,225.0 | View | |
| Feb 20, 2026 | CEO and President | F | D | 3,788.0 | 206.99 | 784,078.12 | 130,153.0 | View | |
| Feb 20, 2026 | CEO and President | F | D | 2,396.0 | 210.01 | 503,183.96 | 133,941.0 | View | |
| Feb 20, 2026 | CEO and President | A | A | 15,857.0 | 0.0 | 0.0 | 136,337.0 | View | |
| Feb 20, 2026 | SVP, Corp. Controller & CAO | A | A | 1,688.0 | 0.0 | 0.0 | 1,688.0 | View | |
| Feb 20, 2026 | SVP, Corp. Controller & CAO | F | D | 99.0 | 206.99 | 20,492.01 | 34,560.0 | View | |
| Feb 20, 2026 | SVP, Corp. Controller & CAO | F | D | 83.0 | 210.01 | 17,430.83 | 34,659.0 | View | |
| Feb 20, 2026 | SVP, Corp. Controller & CAO | A | A | 366.0 | 0.0 | 0.0 | 34,742.0 | View | |
| Feb 20, 2026 | SVP & General Counsel | A | A | 9,289.0 | 0.0 | 0.0 | 9,289.0 | View | |
| Feb 20, 2026 | SVP & General Counsel | S | D | 1,111.0 | 204.83 | 227,566.13 | 38,371.0 | View | |
| Feb 20, 2026 | SVP & General Counsel | F | D | 347.0 | 206.99 | 71,825.53 | 39,482.0 | View | |
| Feb 20, 2026 | SVP & General Counsel | F | D | 301.0 | 210.01 | 63,213.01 | 39,829.0 | View | |
| Feb 20, 2026 | SVP & General Counsel | A | A | 2,013.0 | 0.0 | 0.0 | 40,130.0 | View | |
| Feb 20, 2026 | SVP, Clinical Solutions | A | A | 9,853.0 | 0.0 | 0.0 | 9,853.0 | View | |
| Feb 20, 2026 | SVP, Clinical Solutions | L | A | 16.0 | 183.516 | 2,936.26 | 10,065.0 | View | |
| Feb 20, 2026 | SVP, Clinical Solutions | A | A | 2,135.0 | 0.0 | 0.0 | 10,049.0 | View | |
| Feb 20, 2026 | SVP, Clinical Solutions | F | D | 259.0 | 206.99 | 53,610.41 | 7,914.0 | View | |
| Feb 20, 2026 | SVP, Clinical Solutions | F | D | 252.0 | 210.01 | 52,922.52 | 8,173.0 | View | |
| Feb 20, 2026 | EVP, Regional Businesses | A | A | 13,514.0 | 0.0 | 0.0 | 13,514.0 | View | |
| Feb 20, 2026 | EVP, Regional Businesses | S | D | 1,433.0 | 204.83 | 293,521.39 | 68,402.0 | View | |
| Feb 20, 2026 | EVP, Regional Businesses | F | D | 728.0 | 206.99 | 150,688.72 | 69,835.0 | View | |
| Feb 20, 2026 | EVP, Regional Businesses | F | D | 433.0 | 210.01 | 90,934.33 | 70,563.0 | View | |
| Feb 20, 2026 | EVP, Regional Businesses | A | A | 2,928.0 | 0.0 | 0.0 | 70,996.0 | View | |
| Feb 20, 2026 | — | L | A | 67.0 | 183.513 | 12,295.37 | 17,104.0 | View | |
| Feb 20, 2026 | — | L | A | 6.0 | 183.51 | 1,101.06 | 2,704.0 | View | |
| Feb 20, 2026 | Executive Vice President & CFO | A | A | 18,303.0 | 0.0 | 0.0 | 18,303.0 | View | |
| Feb 20, 2026 | Executive Vice President & CFO | A | A | 69.0 | 183.514 | 12,662.47 | 27,910.0 | View | |
| Feb 20, 2026 | Executive Vice President & CFO | F | D | 1,010.0 | 206.99 | 209,059.9 | 27,841.0 | View | |
| Feb 20, 2026 | Executive Vice President & CFO | F | D | 855.0 | 210.01 | 179,558.55 | 28,851.0 | View | |
| Feb 20, 2026 | Executive Vice President & CFO | A | A | 3,965.0 | 0.0 | 0.0 | 29,706.0 | View | |
| Feb 20, 2026 | SVP for Diagnostic Services | A | A | 9,009.0 | 0.0 | 0.0 | 9,009.0 | View | |
| Feb 20, 2026 | SVP for Diagnostic Services | S | D | 958.0 | 204.83 | 196,227.14 | 15,838.0 | View | |
| Feb 20, 2026 | SVP for Diagnostic Services | F | D | 293.0 | 206.99 | 60,648.07 | 16,796.0 | View | |
| Feb 20, 2026 | SVP for Diagnostic Services | F | D | 244.0 | 210.01 | 51,242.44 | 17,089.0 | View | |
| Feb 20, 2026 | SVP for Diagnostic Services | A | A | 1,952.0 | 0.0 | 0.0 | 17,333.0 | View | |
| Feb 20, 2026 | SVP & Chief Commercial Officer | A | A | 7,332.0 | 0.0 | 0.0 | 7,332.0 | View | |
| Feb 20, 2026 | SVP & Chief Commercial Officer | L | A | 15.0 | 183.51 | 2,752.65 | 8,696.0 | View | |
| Feb 20, 2026 | SVP & Chief Commercial Officer | F | D | 230.0 | 206.99 | 47,607.7 | 8,681.0 | View | |
| Feb 20, 2026 | SVP & Chief Commercial Officer | F | D | 205.0 | 210.01 | 43,052.05 | 8,911.0 | View | |
| Feb 20, 2026 | SVP & Chief Commercial Officer | A | A | 1,586.0 | 0.0 | 0.0 | 9,116.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | M | D | 26,165.0 | 112.17 | 2,934,928.05 | 0.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | S | D | 351.0 | 209.1024 | 73,394.94 | 68,068.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | S | D | 1,619.0 | 208.2107 | 337,093.12 | 68,419.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | S | D | 3,500.0 | 207.0822 | 724,787.7 | 70,038.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | S | D | 10,122.0 | 206.3706 | 2,088,883.21 | 73,538.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | S | D | 10,573.0 | 205.2072 | 2,169,655.73 | 83,660.0 | View | |
| Feb 17, 2026 | EVP, Regional Businesses | M | A | 26,165.0 | 112.17 | 2,934,928.05 | 94,233.0 | View | |
| Feb 12, 2026 | SVP for Diagnostic Services | M | D | 5,662.0 | 121.805 | 689,659.91 | 0.0 | View | |
| Feb 12, 2026 | SVP for Diagnostic Services | S | D | 5,662.0 | 204.0 | 1,155,048.0 | 15,381.0 | View | |
| Feb 12, 2026 | SVP for Diagnostic Services | M | A | 5,662.0 | 121.805 | 689,659.91 | 21,043.0 | View | |
| Feb 12, 2026 | SVP for Diagnostic Services | A | A | 48.0 | 183.512 | 8,808.58 | 15,381.0 | View | |
| Nov 28, 2025 | CEO and President | M | D | 55,093.0 | 95.795 | 5,277,633.94 | 0.0 | View | |
| Nov 28, 2025 | CEO and President | S | D | 4,747.0 | 192.9717 | 916,036.66 | 120,480.0 | View | |
| Nov 28, 2025 | CEO and President | S | D | 41,004.0 | 192.2715 | 7,883,900.59 | 125,227.0 | View | |
| Nov 28, 2025 | CEO and President | S | D | 9,342.0 | 191.5888 | 1,789,822.57 | 166,231.0 | View | |
| Nov 28, 2025 | CEO and President | M | A | 55,093.0 | 95.795 | 5,277,633.94 | 175,573.0 | View | |
| Nov 28, 2025 | — | S | D | 1,250.0 | 191.76 | 239,700.0 | 17,037.0 | View | |
| Nov 20, 2025 | SVP & Chief Commercial Officer | M | D | 100.0 | 143.33 | 14,333.0 | 7,484.0 | View | |
| Nov 20, 2025 | SVP & Chief Commercial Officer | M | D | 7,846.0 | 144.47 | 1,133,511.62 | 0.0 | View | |
| Nov 20, 2025 | SVP & Chief Commercial Officer | S | D | 7,946.0 | 187.35 | 1,488,683.1 | 7,530.0 | View | |
| Nov 20, 2025 | SVP & Chief Commercial Officer | M | A | 100.0 | 143.33 | 14,333.0 | 15,476.0 | View | |
| Nov 20, 2025 | SVP & Chief Commercial Officer | M | A | 7,846.0 | 144.47 | 1,133,511.62 | 15,376.0 | View | |
| Nov 07, 2025 | CEO and President | F | D | 7,143.0 | 175.57 | 1,254,096.51 | 120,480.0 | View | |
| Oct 24, 2025 | — | A | A | 6.0 | 189.089 | 1,134.53 | 2,698.0 | View | |
| Oct 24, 2025 | SVP & Chief Commercial Officer | A | A | 15.0 | 189.077 | 2,836.16 | 7,530.0 | View | |
| Oct 24, 2025 | — | A | A | 70.0 | 189.082 | 13,235.74 | 18,287.0 | View | |
| Oct 24, 2025 | — | I | D | 4,413.28 | 190.58 | 841,083.66 | 0.0 | View | |
| Oct 24, 2025 | — | S | D | 1,482.0 | 182.4 | 270,316.8 | 29,431.0 | View | |
| Oct 24, 2025 | SVP for Diagnostic Services | A | A | 46.0 | 189.079 | 8,697.63 | 15,333.0 | View | |
| Oct 24, 2025 | Executive Vice President & CFO | A | A | 68.0 | 189.081 | 12,857.51 | 25,741.0 | View | |
| Oct 24, 2025 | SVP, Clinical Solutions | A | A | 15.0 | 189.076 | 2,836.14 | 8,379.0 | View |